• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-493-5p通过靶向岩藻糖基转移酶4减弱人乳腺癌的侵袭性和致瘤性。

miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.

作者信息

Zhao Lifen, Feng Xiaobin, Song Xiaobo, Zhou Huimin, Zhao Yongfu, Cheng Lei, Jia Li

机构信息

College of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.

Department of Medical Biology, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway.

出版信息

Oncol Rep. 2016 Aug;36(2):1007-15. doi: 10.3892/or.2016.4882. Epub 2016 Jun 16.

DOI:10.3892/or.2016.4882
PMID:27375041
Abstract

Breast cancer is a leading cause of cancer-related mortality among women. Altered fucosylation was found to be closely associated with tumorigenesis and metastasis of breast cancer. MicroRNAs (miRNAs) are important regulators of cell proliferation and metastasis, and aberrant miRNA expression has been observed in breast cancer. The present study aimed to evaluate the level of fucosyltransferase IV (FUT4) and miR-493-5p in breast cancer and investigate their relationship. In the present study, we demonstrated the differential expressional profiles of FUT4 and miR‑493-5p in 29 clinical breast cancer tissues, matched adjacent tissue samples and two breast carcinoma cell lines (MCF-7 and MDA-MB-231). Briefly, altered expression levels of FUT4 modified the invasive activities and tumorigenicity of the MCF-7 and MDA-MB-231 cells. Further study demonstrated that miR-493-5p plays a role as a suppressor in breast cancer cell invasion and tumorigenicity. Moreover, the expression levels of miR-493-5p were inversely proportional to those of FUT4 both at the mRNA and protein levels. Luciferase reporter assays confirmed that miR‑493-5p bound to the 3'-untranslated (3'-UTR) region of FUT4, and inhibited the expression of FUT4 in breast cancer cells. Taken together, our data suggest that FUT4 may have a potential role in the treatment of breast cancer, as well as miR-493-5p is a novel regulator of invasiveness and tumorigenicity of breast cancer cells through targeting FUT4. The miR-493-5p/FUT4 pathway has therapeutic potential in breast cancer.

摘要

乳腺癌是女性癌症相关死亡的主要原因。研究发现,岩藻糖基化改变与乳腺癌的发生和转移密切相关。微小RNA(miRNA)是细胞增殖和转移的重要调节因子,在乳腺癌中已观察到miRNA表达异常。本研究旨在评估乳腺癌中岩藻糖基转移酶IV(FUT4)和miR-493-5p的水平,并研究它们之间的关系。在本研究中,我们展示了FUT4和miR-493-5p在29例临床乳腺癌组织、配对的相邻组织样本以及两种乳腺癌细胞系(MCF-7和MDA-MB-231)中的差异表达谱。简而言之,FUT4表达水平的改变影响了MCF-7和MDA-MB-231细胞的侵袭活性和致瘤性。进一步研究表明,miR-493-5p在乳腺癌细胞侵袭和致瘤性中起抑制作用。此外,miR-493-5p的表达水平在mRNA和蛋白质水平上均与FUT4的表达水平呈负相关。荧光素酶报告基因检测证实,miR-493-5p与FUT4的3'非翻译区(3'-UTR)结合,并抑制乳腺癌细胞中FUT4的表达。综上所述,我们的数据表明FUT4可能在乳腺癌治疗中具有潜在作用,并且miR-493-5p是通过靶向FUT4调控乳腺癌细胞侵袭性和致瘤性的新型调节因子。miR-493-5p/FUT4通路在乳腺癌治疗中具有潜在应用价值。

相似文献

1
miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.微小RNA-493-5p通过靶向岩藻糖基转移酶4减弱人乳腺癌的侵袭性和致瘤性。
Oncol Rep. 2016 Aug;36(2):1007-15. doi: 10.3892/or.2016.4882. Epub 2016 Jun 16.
2
Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.岩藻糖基化增加通过miR-224-3p靶向FUT4在乳腺癌细胞多药耐药中起关键作用。
Gene. 2016 Mar 10;578(2):232-41. doi: 10.1016/j.gene.2015.12.028. Epub 2015 Dec 14.
3
MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.微小RNA-340通过靶向Wnt信号通路抑制乳腺癌细胞的迁移、侵袭和转移。
Tumour Biol. 2016 Jul;37(7):8993-9000. doi: 10.1007/s13277-015-4513-9. Epub 2016 Jan 12.
4
MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.微小RNA-31调控乳腺癌细胞中G蛋白α-13(GNA13)的表达及细胞侵袭。
Mol Cancer. 2015 Mar 26;14:67. doi: 10.1186/s12943-015-0337-x.
5
miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.miR-424-5p 通过靶向双皮质素样激酶 1 调节基底样乳腺癌细胞的增殖、迁移和侵袭。
Biomed Pharmacother. 2018 Jun;102:147-152. doi: 10.1016/j.biopha.2018.03.018. Epub 2018 Mar 22.
6
Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.miR-502-5p通过下调TRAF2在乳腺癌中的抑制作用。
Oncol Rep. 2014 May;31(5):2085-92. doi: 10.3892/or.2014.3105. Epub 2014 Mar 21.
7
MicroRNA-106b targets FUT6 to promote cell migration, invasion, and proliferation in human breast cancer.微小RNA-106b靶向岩藻糖基转移酶6以促进人乳腺癌细胞的迁移、侵袭和增殖。
IUBMB Life. 2016 Sep;68(9):764-75. doi: 10.1002/iub.1541. Epub 2016 Aug 13.
8
miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.微小RNA-411-5p通过靶向生长因子受体结合蛋白2抑制乳腺癌细胞的增殖和转移。
Biochem Biophys Res Commun. 2016 Aug 5;476(4):607-613. doi: 10.1016/j.bbrc.2016.06.006. Epub 2016 Jun 3.
9
MiR-125a-5p suppresses bladder cancer progression through targeting FUT4.miR-125a-5p 通过靶向 FUT4 抑制膀胱癌进展。
Biomed Pharmacother. 2018 Dec;108:1039-1047. doi: 10.1016/j.biopha.2018.09.100. Epub 2018 Sep 28.
10
miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.miR-381 通过靶向 CXCR4 抑制乳腺癌细胞增殖、上皮间质转化和转移。
Biomed Pharmacother. 2017 Feb;86:426-433. doi: 10.1016/j.biopha.2016.12.051. Epub 2016 Dec 21.

引用本文的文献

1
MiR-493-5p functions as a tumour suppressor in head and neck squamous cell carcinoma progression by targeting HIF-1α.微小RNA-493-5p通过靶向缺氧诱导因子-1α在头颈部鳞状细胞癌进展中发挥肿瘤抑制作用。
Discov Oncol. 2025 May 24;16(1):899. doi: 10.1007/s12672-025-02690-1.
2
Screening and Studying of Blood miRNAs as Potential Diagnostic Markers for Papillary Thyroid Carcinoma.血液中微小RNA作为甲状腺乳头状癌潜在诊断标志物的筛选与研究
Onco Targets Ther. 2024 Dec 10;17:1173-1185. doi: 10.2147/OTT.S489559. eCollection 2024.
3
The Overexpressed MicroRNAs miRs-182, 155, 493, 454, and U6 snRNA and Underexpressed let-7c, miR-328, and miR-451a as Potential Biomarkers in Invasive Breast Cancer and Their Clinicopathological Significance.
过表达的微小RNA miR-182、155、493、454和U6小核RNA以及低表达的let-7c、miR-328和miR-451a作为浸润性乳腺癌的潜在生物标志物及其临床病理意义
Oncology. 2025;103(2):112-127. doi: 10.1159/000540863. Epub 2024 Aug 12.
4
Death-associated protein 3 in cancer-discrepant roles of DAP3 in tumours and molecular mechanisms.癌症中的死亡相关蛋白3——DAP3在肿瘤中的不同作用及分子机制
Front Oncol. 2024 Jan 30;13:1323751. doi: 10.3389/fonc.2023.1323751. eCollection 2023.
5
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!雌激素受体阴性乳腺癌与微小RNA:需要解读的内容远不止病理学家所能看到的!
Biomedicines. 2023 Aug 18;11(8):2300. doi: 10.3390/biomedicines11082300.
6
Effect of miR-493-5p on proliferation and differentiation of myoblast by targeting ANKRD17.miR-493-5p 通过靶向 ANKRD17 对肌母细胞增殖和分化的影响。
Cell Tissue Res. 2023 Jul;393(1):119-132. doi: 10.1007/s00441-023-03777-3. Epub 2023 May 13.
7
New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer.微小RNA在三阴性乳腺癌诊断和预后中的作用的新进展
Front Mol Biosci. 2023 Apr 13;10:1162463. doi: 10.3389/fmolb.2023.1162463. eCollection 2023.
8
The Mutual Relationship between Glycosylation and Non-Coding RNAs in Cancer and Other Physio-Pathological Conditions.糖基化与非编码 RNA 在癌症及其他生理病理条件下的相互关系。
Int J Mol Sci. 2022 Dec 13;23(24):15804. doi: 10.3390/ijms232415804.
9
Differential expression profiles of miRNA in the serum of sarcopenic rats.少肌症大鼠血清中miRNA的差异表达谱
Biochem Biophys Rep. 2022 Mar 17;30:101251. doi: 10.1016/j.bbrep.2022.101251. eCollection 2022 Jul.
10
miRNA and lncRNA Expression Networks Modulate Cell Cycle and DNA Repair Inhibition in Senescent Prostate Cells.miRNA 和 lncRNA 表达网络调节衰老前列腺细胞中的细胞周期和 DNA 修复抑制。
Genes (Basel). 2022 Jan 24;13(2):208. doi: 10.3390/genes13020208.